Literature DB >> 14753447

Neuropeptide release influences brain edema formation after diffuse traumatic brain injury.

R Vink1, A Young, C J Bennett, X Hu, C O Connor, I Cernak, A J Nimmo.   

Abstract

The mechanisms associated with edema formation after traumatic brain injury (TBI) have not been fully elucidated. In peripheral tissue injury, the neurogenic component of inflammation plays a significant role in increased vascular permeability and edema formation. However, few studies have examined the role of neuropeptide induced neurogenic inflammation following TBI. Adult male Sprague-Dawley rats were either left untreated, or pre-treated with capsaicin (125 mg/kg s.c.) or equal volume vehicle, and injured 14 days later using the 2-meter impact-acceleration model. Subgroups of animals were assessed for blood brain barrier (BBB) permeability (Evans Blue), brain edema (wet weight/dry weight) and functional outcome (Barnes maze and Rotarod) for up to 2 weeks post-trauma. Increased BBB permeability was present in untreated animals between 3 and 6 h after injury but not at later time-points. Edema was maximal at 5 h after trauma, declined and then significantly increased over the 5 days post-trauma. In contrast, capsaicin pre-treated, neuropeptide-depleted animals exhibited no significant increase in BBB permeability or edema compared to vehicle treated animals after injury. Notably, motor and cognitive impairments were significantly reduced in the capsaicin-pretreated animals. We conclude that neurogenic inflammation contributes to the development of edema and posttraumatic deficits after diffuse TBI.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14753447     DOI: 10.1007/978-3-7091-0651-8_55

Source DB:  PubMed          Journal:  Acta Neurochir Suppl        ISSN: 0065-1419


  20 in total

1.  Pseudoginsenoside-F11 attenuates cerebral ischemic injury by alleviating autophagic/lysosomal defects.

Authors:  Yue-Yang Liu; Tian-Yu Zhang; Xue Xue; Dong-Mei Liu; Hao-Tian Zhang; Lin-Lin Yuan; Ying-Lu Liu; Han-Lin Yang; Shi-Bo Sun; Cheng Zhang; He-Song Xu; Chun-Fu Wu; Jing-Yu Yang
Journal:  CNS Neurosci Ther       Date:  2017-05-09       Impact factor: 5.243

2.  Experimental diffuse brain injury results in regional alteration of gross vascular morphology independent of neuropathology.

Authors:  Jenna M Ziebell; Rachel K Rowe; Jordan L Harrison; Katharine C Eakin; Taylor Colburn; F Anthony Willyerd; Jonathan Lifshitz
Journal:  Brain Inj       Date:  2015-12-08       Impact factor: 2.311

3.  Does the administration of melatonin during post-traumatic brain injury affect cytokine levels?

Authors:  Fatemeh Dehghan; Nader Shahrokhi; Mohammad Khaksari; Zahra Soltani; Gholamreza Asadikorom; Ali Najafi; Nava Shahrokhi
Journal:  Inflammopharmacology       Date:  2017-11-20       Impact factor: 4.473

4.  Neuronal-targeted TFEB rescues dysfunction of the autophagy-lysosomal pathway and alleviates ischemic injury in permanent cerebral ischemia.

Authors:  Yueyang Liu; Xue Xue; Haotian Zhang; Xiaohang Che; Jing Luo; Ping Wang; Jiaoyan Xu; Zheng Xing; Linlin Yuan; Yinglu Liu; Xiaoxiao Fu; Dongmei Su; Shibo Sun; Haonan Zhang; Chunfu Wu; Jingyu Yang
Journal:  Autophagy       Date:  2018-10-18       Impact factor: 16.016

5.  Neurokinin-1 receptor inhibition reverses ischaemic brain injury and dementia in bilateral common carotid artery occluded rats: possible mechanisms.

Authors:  Jaspreet Kaur; Shweta Sharma; Manpreet Sandhu; Saurabh Sharma
Journal:  Inflammopharmacology       Date:  2016-07-05       Impact factor: 4.473

6.  Inhibition of nuclear factor-κB by 6-O-acetyl shanzhiside methyl ester protects brain against injury in a rat model of ischemia and reperfusion.

Authors:  Wanglin Jiang; Shuping Zhang; Fenghua Fu; Haibo Zhu; Jian Hou
Journal:  J Neuroinflammation       Date:  2010-09-14       Impact factor: 8.322

7.  NK1 receptor blockade is ineffective in improving outcome following a balloon compression model of spinal cord injury.

Authors:  Anna Victoria Leonard; Emma Thornton; Robert Vink
Journal:  PLoS One       Date:  2014-05-23       Impact factor: 3.240

8.  Inhibitory effect on cerebral inflammatory response following traumatic brain injury in rats: a potential neuroprotective mechanism of N-acetylcysteine.

Authors:  Gang Chen; Jixin Shi; Zhigang Hu; Chunhua Hang
Journal:  Mediators Inflamm       Date:  2008       Impact factor: 4.711

9.  Treatment with the NK1 antagonist emend reduces blood brain barrier dysfunction and edema formation in an experimental model of brain tumors.

Authors:  Elizabeth Harford-Wright; Kate M Lewis; Mounir N Ghabriel; Robert Vink
Journal:  PLoS One       Date:  2014-05-12       Impact factor: 3.240

10.  The role of substance p in ischaemic brain injury.

Authors:  Renée J Turner; Robert Vink
Journal:  Brain Sci       Date:  2013-01-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.